Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.60 USD | +1.41% | +3.31% | -15.07% |
Capitalization | 6.14B 5.86B 5.43B 4.82B 8.68B 521B 9.64B 67.45B 24.98B 214B 23.07B 22.55B 936B | P/E ratio 2024 * |
19.6x | P/E ratio 2025 * | 128x |
---|---|---|---|---|---|
Enterprise value | 10.17B 9.7B 8.99B 7.97B 14.38B 862B 15.97B 112B 41.35B 354B 38.19B 37.34B 1,550B | EV / Sales 2024 * |
2.29x | EV / Sales 2025 * | 2.18x |
Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Elanco Animal Health Incorporated
1 day | +1.41% | ||
1 week | +3.31% | ||
Current month | -4.20% | ||
1 month | -11.32% | ||
3 months | -12.60% | ||
6 months | -31.04% | ||
Current year | -15.07% |
Director | Title | Age | Since |
---|---|---|---|
Jeffrey Simmons
CEO | Chief Executive Officer | 56 | 2018-06-30 |
Todd Young
DFI | Director of Finance/CFO | 52 | 2018-12-13 |
Chief Tech/Sci/R&D Officer | - | - |
Manager | Title | Age | Since |
---|---|---|---|
Jeffrey Simmons
BRD | Director/Board Member | 56 | 2018-06-30 |
R. Hoover
CHM | Chairman | 78 | 2018-04-30 |
Kapila Anand
BRD | Director/Board Member | 70 | 2018-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.88% | 380 M€ | +9.03% | - | |
10.49% | 1 M€ | -.--% | ||
0.35% | 20 M€ | +16.14% | - | |
0.33% | 2 M€ | -.--% |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+1.41% | +3.31% | -0.43% | -54.38% | 6.14B | ||
+0.71% | +1.55% | -6.03% | -23.38% | 79.73B | ||
+1.36% | +1.45% | +45.90% | -8.11% | 4.09B | ||
-1.52% | +3.01% | +8.70% | -26.64% | 2.9B | ||
+0.37% | -3.87% | +53.95% | -38.05% | 1.94B | ||
+1.70% | -1.78% | +21.38% | -10.18% | 1.27B | ||
+2.22% | +1.66% | -34.84% | -36.57% | 1.02B | ||
-0.26% | +1.43% | -15.62% | -40.78% | 1B | ||
+1.70% | -2.39% | -14.43% | -41.23% | 950M | ||
+2.94% | +0.30% | +116.04% | +22.86% | 936M | ||
Average | +1.06% | -0.19% | +17.46% | -25.65% | 10B | |
Weighted average by Cap. | +0.76% | -0.08% | -0.94% | -24.91% |
2024 * | 2025 * | |
---|---|---|
Net sales | 4.43B 4.23B 3.92B 3.48B 6.27B 376B 6.96B 48.7B 18.03B 155B 16.65B 16.29B 676B | 4.55B 4.34B 4.03B 3.57B 6.44B 386B 7.15B 50.01B 18.52B 159B 17.1B 16.72B 694B |
Net income | 320M 305M 283M 251M 452M 27.1B 502M 3.51B 1.3B 11.14B 1.2B 1.17B 48.73B | 16.16M 15.41M 14.29M 12.68M 22.85M 1.37B 25.38M 178M 65.74M 563M 60.71M 59.36M 2.46B |
Net Debt | 4.03B 3.84B 3.56B 3.16B 5.69B 341B 6.32B 44.23B 16.38B 140B 15.12B 14.79B 614B | 3.8B 3.62B 3.36B 2.98B 5.37B 322B 5.96B 41.7B 15.44B 132B 14.26B 13.95B 579B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-11 | 12.66 $ | +1.89% | 1,419,963 |
24-12-10 | 12.42 $ | -3.57% | 5,288,941 |
24-12-09 | 12.88 $ | +3.04% | 4,276,903 |
24-12-06 | 12.50 $ | +3.14% | 4,585,191 |
24-12-05 | 12.12 $ | -1.06% | 6,369,170 |
Delayed Quote Nyse, December 11, 2024 at 02:35 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- ELAN Stock